We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$984M
AUM Growth
+$75.1M
Cap. Flow
+$13.9M
Cap. Flow %
1.41%
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.77M
2
GIS icon
General Mills
GIS
+$4.51M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$3.41M
4
JNJ icon
Johnson & Johnson
JNJ
+$3.27M
5
KHC icon
Kraft Heinz
KHC
+$3.04M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$11.9M
2
AMGN icon
Amgen
AMGN
+$2.76M
3
GILD icon
Gilead Sciences
GILD
+$2.63M
4
BIIB icon
Biogen
BIIB
+$1.96M
5
CELG
Celgene Corp
CELG
+$1.61M

Sector Composition

Rank Sector Weight
1 Financials 35.78%
2 Healthcare 22.27%
3 Industrials 11.22%
4 Technology 7.01%
5 Consumer Staples 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
51
Mastercard
MA
$492B
$2.23M 0.23%
10,000
– –
JKHY icon
52
Jack Henry & Associates
JKHY
$10.9B
$2.19M 0.22%
13,700
– –
KO icon
53
Coca-Cola
KO
$372B
$2.13M 0.22%
46,000
– –
DVAX
54
DELISTED
Dynavax Technologies
DVAX
$1.93M 0.2%
155,755
+25,000
+19% +$338K
AXP icon
55
American Express
AXP
$230B
$1.87M 0.19%
17,600
– –
MCD icon
56
McDonald's
MCD
$194B
$1.68M 0.17%
10,060
– –
HDV
57
iShares Core High Dividend ETF
HDV
$15B
$1.68M 0.17%
92,500
+66,000
+249% +$1.17M
SRPT icon
58
Sarepta Therapeutics
SRPT
$1.92B
$1.61M 0.16%
10,000
– –
ALDX icon
59
Aldeyra Therapeutics
ALDX
$91.1M
$1.49M 0.15%
107,858
– –
CHL
60
DELISTED
China Mobile Limited
CHL
$1.46M 0.15%
29,800
– –
MDR
61
DELISTED
McDermott International
MDR
$1.41M 0.14%
76,638
– –
VWO icon
62
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$1.4M 0.14%
34,200
+17,200
+101% +$724K
BNY
63
Bank of New York Mellon
BNY
$109B
$1.29M 0.13%
+25,300
New +$1.33M
SYNT
64
DELISTED
Syntel Inc
SYNT
$1.28M 0.13%
31,270
– –
STOR
65
DELISTED
STORE Capital Corporation
STOR
$1.02M 0.1%
36,700
– –
DNOW icon
66
DNOW Inc
DNOW
$3.01B
$921K 0.09%
55,675
– –
BTI icon
67
British American Tobacco
BTI
$122B
$902K 0.09%
19,350
– –
TGTX icon
68
TG Therapeutics
TGTX
$7.64B
$896K 0.09%
160,000
– –
ST icon
69
Sensata Technologies
ST
$6.73B
$892K 0.09%
18,000
– –
OCUL icon
70
Ocular Therapeutix
OCUL
$2.14B
$826K 0.08%
120,001
+39,990
+50% +$251K
DO
71
DELISTED
Diamond Offshore Drilling
DO
$704K 0.07%
35,200
– –
PGNX
72
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$627K 0.06%
100,000
-100,000
-50% -$768K
ADMS
73
DELISTED
Adamas Pharmaceuticals
ADMS
$601K 0.06%
30,000
– –
CALA
74
DELISTED
Calithera Biosciences, Inc
CALA
$525K 0.05%
5,000
– –
L icon
75
Loews
L
$23.1B
$487K 0.05%
9,700
– –
1 2
3
4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2018 Portfolio in Review

As of Q3 2018, Hikari Power held 135 positions worth $984M, up 8.3% from $908M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hikari Power's Q3 2018 filing shows 7 new, 20 increased, 9 reduced and 8 closed positions. Its largest new stake was Bank of New York Mellon: 25,300 shares worth $1.29M. The largest sale was IBM, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2018 buy was Bank of New York Mellon: 25,300 shares worth $1.29M.
  • Hikari Power added most to Allergan plc in Q3 2018, an estimated $6.77M increase.
  • Hikari Power's biggest Q3 2018 reduction was IBM, cutting an estimated $11.9M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2018, selling an estimated $916K.
  • Hikari Power's ten largest holdings make up 55% of its $984M portfolio in Q3 2018.
  • Hikari Power opened 7 new positions and closed 8 in Q3 2018.
  • Hikari Power's portfolio value rose 8.3% quarter-over-quarter to $984M.

Based on Hikari Power's 13F filing for Q3 2018, filed 31 Oct 2018.